{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:41:42Z","timestamp":1784324502729,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cyto.2021.155523","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:56:12Z","timestamp":1617234972000},"page":"155523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity"],"prefix":"10.1016","volume":"143","author":[{"given":"Yueting","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-2781","authenticated-orcid":false,"given":"Huaqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanlu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5619-1614","authenticated-orcid":false,"given":"Yirong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cyto.2021.155523_b0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.15585\/mmwr.mm6905e1","article-title":"Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020","volume":"69","author":"Patel","year":"2020","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"10223","key":"10.1016\/j.cyto.2021.155523_b0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cyto.2021.155523_b0015","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet. Infect. Dis"},{"issue":"9366","key":"10.1016\/j.cyto.2021.155523_b0020","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2021.155523_b0025","first-page":"301","article-title":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia","volume":"29","author":"Saad","year":"2014","journal-title":"Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis."},{"issue":"11","key":"10.1016\/j.cyto.2021.155523_b0030","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.cyto.2021.155523_b0035","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/ajh.25979","article-title":"Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism","volume":"95","author":"Stefely","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.cyto.2021.155523_b0040","article-title":"Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality","volume":"96","author":"Meijenfeldt","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.cyto.2021.155523_b0045","doi-asserted-by":"crossref","first-page":"e0241329","DOI":"10.1371\/journal.pone.0241329","article-title":"The values of coagulation function in COVID-19 patients","volume":"15","author":"Jin","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155523_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00747","article-title":"COVID-19 Sepsis and Microcirculation Dysfunction","volume":"11","author":"Colantuoni","year":"2020","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155523_b0055","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14726","article-title":"SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation","volume":"9","author":"\u00d8stergaard","year":"2021","journal-title":"Physiol. Reports"},{"issue":"5","key":"10.1016\/j.cyto.2021.155523_b0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5603\/ARM.a2020.0123","article-title":"Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab","volume":"88","author":"Mohebbi","year":"2020","journal-title":"Adv. Respiratory Med."},{"issue":"5","key":"10.1016\/j.cyto.2021.155523_b0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Seminars Immunopathol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155523_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4155\/fmc-2016-0181","article-title":"Current and future developments in the treatment of virus-induced hypercytokinemia","volume":"9","author":"Wong","year":"2017","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.cyto.2021.155523_b0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1440-1843.2006.00942.x","article-title":"Temporal changes in cytokine\/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome","volume":"11","author":"CHIEN","year":"2006","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.cyto.2021.155523_b0080","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/IAI.72.8.4410-4415.2004","article-title":"Analysis of serum cytokines in patients with severe acute respiratory syndrome","volume":"72","author":"Zhang","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2021.155523_b0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11908-014-0451-8","article-title":"Biomarkers for community-acquired pneumonia in the emergency department","volume":"16","author":"Florin","year":"2014","journal-title":"Curr Infect Dis Rep."},{"issue":"10223","key":"10.1016\/j.cyto.2021.155523_b0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cyto.2021.155523_b0095","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/v4050833","article-title":"Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?","volume":"4","author":"Cecere","year":"2012","journal-title":"Viruses."},{"issue":"4","key":"10.1016\/j.cyto.2021.155523_b0100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1086\/381535","article-title":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome","volume":"189","author":"Li","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155523_b0105","first-page":"985","article-title":"Rapid loss of both CD4+ and CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory syndrome","volume":"116","author":"Li","year":"2003","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.cyto.2021.155523_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6491738","article-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development","volume":"2019","author":"Mubarak","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cyto.2021.155523_b0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.cyto.2021.155523_b0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virusres.2009.07.014","article-title":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients","volume":"145","author":"Kong","year":"2009","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.cyto.2021.155523_b0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jir.2006.26.309","article-title":"SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues","volume":"26","author":"Baas","year":"2006","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.cyto.2021.155523_b0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.cyto.2021.155523_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection","volume":"6","author":"Totura","year":"2015","journal-title":"mBio."},{"issue":"6","key":"10.1016\/j.cyto.2021.155523_b0140","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1164\/ajrccm.153.6.8665045","article-title":"Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1","volume":"153","author":"Pugin","year":"1996","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"9","key":"10.1016\/j.cyto.2021.155523_b0145","doi-asserted-by":"crossref","first-page":"e1006640","DOI":"10.1371\/journal.ppat.1006640","article-title":"Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology","volume":"13","author":"Pyle","year":"2017","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.cyto.2021.155523_b0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.icb.7100026","article-title":"A question of self-preservation: immunopathology in influenza virus infection","volume":"85","author":"La Gruta","year":"2007","journal-title":"Immunol. Cell Biol."},{"issue":"12","key":"10.1016\/j.cyto.2021.155523_b0155","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz520","article-title":"Host Inflammatory Biomarkers of Disease Severity in Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis","volume":"6","author":"Fernandes","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2021.155523_b0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/INF.0000000000001364","article-title":"Assessment of Cytokine and Chemokine Signatures as Potential Biomarkers of Childhood Community-acquired Pneumonia Severity: A Nested Cohort Study in India","volume":"36","author":"Saghafian-Hedengren","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155523_b0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12890-016-0324-z","article-title":"The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia","volume":"16","author":"de Brito","year":"2016","journal-title":"BMC Pulmonary Med."},{"issue":"9","key":"10.1016\/j.cyto.2021.155523_b0170","doi-asserted-by":"crossref","first-page":"e0138978","DOI":"10.1371\/journal.pone.0138978","article-title":"Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia","volume":"10","author":"Haugen","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.cyto.2021.155523_b0175","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.0802923","article-title":"IL-6 is required for airway mucus production induced by inhaled fungal allergens","volume":"183","author":"Neveu","year":"2009","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.cyto.2021.155523_b0180","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1074\/jbc.M210429200","article-title":"Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine\/autocrine loop","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2021.155523_b0185","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.02.00295102","article-title":"Systemic cytokine levels in community-acquired pneumonia and their association with disease severity","volume":"20","author":"Antunes","year":"2002","journal-title":"Europ. Respiratory J."},{"issue":"3","key":"10.1016\/j.cyto.2021.155523_b0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma: an undervalued pathology?","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155523_b0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/600072","article-title":"Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis","volume":"200","author":"Naicker","year":"2009","journal-title":"J. Infect Dis."},{"issue":"4","key":"10.1016\/j.cyto.2021.155523_b0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0952-7915(02)00354-0","article-title":"Links between innate and adaptive immunity via type I interferon","volume":"14","author":"Le Bon","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2021.155523_b0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI17129","article-title":"Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation","volume":"112","author":"McLoughlin","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.cyto.2021.155523_b0210","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.182.2.1099","article-title":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection","volume":"182","author":"Cervantes-Barrag\u00e1n","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2021.155523_b0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cyto.2021.155523_b0220","first-page":"193","article-title":"SARS Immunity and Vaccination","volume":"1","author":"Zhu","year":"2004","journal-title":"Cell Mol. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2021.155523_b0225","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1128\/JVI.79.12.7819-7826.2005","article-title":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis","volume":"79","author":"Cheung","year":"2005","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.cyto.2021.155523_b0230","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1073\/pnas.0711942105","article-title":"Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A\/H5N1 virus","volume":"105","author":"Zheng","year":"2008","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.cyto.2021.155523_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2012.45","article-title":"Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5","volume":"1","author":"Woo","year":"2012","journal-title":"Emerging Microbes Infect."},{"issue":"12","key":"10.1016\/j.cyto.2021.155523_b0240","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1093\/jac\/dkw338","article-title":"A review of treatment modalities for Middle East Respiratory Syndrome","volume":"71","author":"Mo","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cyto.2021.155523_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.574703","article-title":"Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB\/c Mice: Potential Implications for Treating Cytokine Release Syndrome","volume":"11","author":"Rubsamen","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"Supp2","key":"10.1016\/j.cyto.2021.155523_b0250","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.5152\/eurjrheum.2020.20061","article-title":"Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists","volume":"7","author":"Corominas","year":"2020","journal-title":"Europ. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.cyto.2021.155523_b0255","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1093\/cid\/ciaa812","article-title":"Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia","volume":"71","author":"Jordan","year":"2020","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.cyto.2021.155523_b0260","doi-asserted-by":"crossref","first-page":"108631","DOI":"10.1016\/j.clim.2020.108631","article-title":"Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort","volume":"223","author":"Corominas","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2021.155523_b0265","doi-asserted-by":"crossref","first-page":"100553","DOI":"10.1016\/j.eclinm.2020.100553","article-title":"Sarilumab use in severe SARS-CoV-2 pneumonia","volume":"27","author":"Gremese","year":"2020","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.cyto.2021.155523_b0270","first-page":"24","article-title":"Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)","volume":"21","author":"Chen","year":"2021","journal-title":"Exp. Therap. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:01:28Z","timestamp":1760907688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":54,"alternative-id":["S1043466621001034"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155523","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155523"}}